Mr. Jason Birmingham reports

NOVERIS HEALTH SCIENCES JOINS THE BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)

Noveris Health Sciences Inc. has joined the Biotechnology Innovation Organization (BIO), the world's largest advocacy association representing biotechnology companies, academic and research institutions, state and regional biotechnology centres and related organizations across the United States and in more than 35 other countries.

By joining BIO, Noveris is strengthening its participation in the global biotechnology ecosystem and expanding opportunities to engage with industry leaders, strategic partners, investors and policy-makers across the United States and internationally. The company believes that membership in BIO will support greater visibility for Noveris within the broader biotechnology and life sciences community while providing access to BIO's policy committees, investor and partnering events, industry research and cost-savings programs that help foster collaboration and commercialization.

"Joining BIO reflects our commitment to being an active participant in the global biotechnology industry," said Jason Birmingham, president and chief executive officer of Noveris. "We see meaningful value in aligning with an organization that brings together leading biotechnology companies, investors and policy-makers from around the world, and we look forward to contributing to and benefiting from the BIO community as we continue to advance Noveris's strategic priorities."

About Noveris Health Sciences Inc.

Noveris Health Sciences is a biotechnology company focused on the development, advancement and commercialization of health-care technologies and opportunities addressing unmet needs in the market.

We seek Safe Harbor.